Growth Delivered, Costs Inflating — The Margin Question Looms
Nuvama posted 20%+ top-line growth and reiterated 20–25% wealth flow guidance, but management overstated PAT growth on the call. The real tension: can cost inflation and asset management losses erode the margin upside?
₹303.5 Cr
+19.5% YoY
~₹319.5 Cr
+26% YoY · Operating basis
₹16 Cr
Venture fund closure
Nuvama delivered ₹1,366 crore revenue (+20.4% YoY) and ₹303.5 crore PAT (+19.5% YoY) in Q2 FY27. On the call, management claimed ₹937 crore revenue with 21% growth and 26% PAT expansion. The 46% revenue gap remains unexplained — likely a segment vs. consolidated discrepancy — but the PAT story is clearer: a ₹16 crore one-time venture fund closure charge depressed the net number from ₹319 crore operating PAT. Strip that out, and organic growth is solid. The real question is whether cost inflation at 19% employee-cost growth can be managed within the 20–25% organic growth mandate.
Where the profit came from
Operating PAT of ₹319 crore (+26% YoY) reflects strong operating leverage across wealth, private, asset services, and lending. But a ₹16 crore post-tax charge for venture fund amortization — the closure of a pre-winddown fund with remaining distribution costs — brought net PAT to ₹303.5 crore. Management flagged ₹9–10 crore of unamortized cost spread over the next 12 months, so Q3–Q4 will carry a similar drag. The adjusted operating run-rate is the organic number to track; reported is temporarily depressed.
Revenue ₹937 Cr with 21% YoY growth
Consolidated revenue ₹1366.1 Cr, +20.4% YoY; management's ₹937 Cr figure not reconciled
Contradicted
PAT growth 26% on operating side
Operating PAT ₹319 Cr +26% YoY; net PAT ₹303.5 Cr +19.5% YoY post one-time charge
Supported (operating)
Client assets ₹5.5 lakh Cr with 25% growth
Wealth AUM ₹46,000 Cr with 25% YoY growth; supported by ₹3,300 Cr Q2 flows
Supported
Asset services revenue growth 50% YoY
Client assets ₹1.63 lakh Cr, 50% YoY growth; management expects normalization to 4–5%
Supported (acknowledged as exceptional)
What changed on this call
Dividend withheld for H1 FY27 (downgrade) — focus shifted to debt paydown; debt-to-equity target 2.9x → 2.5x
Cost-to-income improved 200 bps YoY to ~50%; targeting further 100–200 bps (upgrade) — efficiency gains offsetting headcount adds
Asset services revenue 50% YoY but management signals normalization to 4–5% going forward (mixed) — macro normalization baked in
Employee cost +19% YoY to ₹382 Cr; ESOP ₹6 Cr/quarter recurring; 250 RM hires planned (downgrade) — structural cost headwind
Organic growth engines — where the 20% came from
Wealth management net flows ₹3,300 crore (Q2 addition), tracking ₹8,300 crore YTD — roughly 11–12% of opening balance, within the 20–25% FY27 guidance range. Lending book ₹6,000 crore (+60% YoY) at stable 2.5% yields. Private wealth ARR assets crossing ₹60–62 lakh crore with ₹5,000 crore new money Q2; transaction income 60–70% recurring monthly. Asset services client assets ₹1.63 lakh crore, though yields normalized to 2.5% post-exceptional Q1 (cash collateral held at 38–40%). Capital markets picked up momentum — 38 IPOs in Q2 vs. 4 in Q1 — but ECM mandates remain ₹85–90 crore revenue range. Asset management AUM ₹12,000 crore still unprofitable; SIF launch expected Nov–Dec (RTA/trustee approvals pending).
The bull-bear ledger
20%+ organic growth across diversified engines (wealth, private, lending, asset services)
Cost-to-income improved 200 bps YoY, tracking to beat 55% consolidated target
Wealth flows ₹3,300 crore Q2 on track for 20–25% FY27 guidance
Consolidated ROE 29%; strong capital efficiency
Employee cost +19% YoY; structural headwind offsetting margin upside
Asset management unprofitable; path to breakeven opaque; one-time charges persisting
Dividend deferred, signaling balance-sheet caution and lower capital return near-term
Clearing competition (18–19 domestic players); market-share erosion risk in JV (49% Motilal-Nuvama stake)
Capital markets cyclical; IPO pipeline driving Q2 beat but normalization expected
How the street is positioned
The stock trades at ₹1,847.8 (as of 13 Nov 2026), holding above its 20-day SMA (₹1,780), 50-day SMA (₹1,760), and well above the 200-day SMA (₹1,574). Trend is bullish, but RSI of 55.7 suggests neutral momentum — not overbought. The 52-week range is ₹1,096.9–₹2,066 (ATH); current price sits 10.6% below the all-time high, representing a modest drawdown. Volume trend is normal. The bearish surprise: for a growth stock delivering 20%+ organic top-line with a strong FY27 guidance reiteration, a 10% ATH drawdown suggests the market is price-checking the execution risk on cost control and asset management profitability.
Ownership dynamics are bullish: FII holdings rose 2.06 percentage points QoQ to 19.0% (from 16.94% in Q4 FY26), indicating institutional accumulation despite the macro uncertainty and equity market volatility. DII holdings are modest at 8.49%, suggesting domestic institutional interest remains secondary. Promoters hold 53.98%, a slight 0.15pp QoQ decline but structurally stable. Block activity (Pabrai Wagons buy/sell at ₹1,652.50) is balanced and shows no insider distress or conviction selling near the highs.
The FII accumulation into a stock trading 10% below ATH, paired with guidance reiteration, suggests the buy-the-dip narrative is live. But the market is not pricing in a step-change — the lack of a post-result pop (and the 10% drawdown) implies investors are viewing this as a steady-state execution story, not an inflection. That consensus is fair: Nuvama is delivering on its organic growth playbook, but until asset management turns profitable and cost inflation stabilizes, valuation multiple expansion is unlikely.
Ranked risks
Cost inflation (employee +19% YoY, ESOP ₹6 Cr/qtr recurring, ₹25 Cr HO move FY27)
HighStructural headwind that offsets margin upside and constrains 55% cost-to-income target. 250 RM hires planned; attrition risk in competitive wealth/clearing market. Management flagged 100–200 bps further improvement, but 19% employee inflation makes that a stretch.
Asset management unprofitability; SIF launch timeline slipping; path to breakeven unquantified
HighStill loss-making after years of subsidy. Guidance said ₹35–40 Cr peak cumulative loss FY27, but no profitability inflection date given. Delays in SIF (now Nov–Dec vs. prior '25 days') and private credit fund (2–3 months) stretch credibility. AM is a drag on consolidated margins.
Domestic clearing license proliferation (18–19 competitors); Nuvama is 49% JV stake (Motilal-Nuvama)
MediumMarket share erosion risk as new entrants crowd a 6–7% high-touch market. Management claims 15–18% mandate share and 25% new-inflow capture, but execution risk is high. JV structure limits Nuvama's control; competition in clearing could depress clearing revenues.
Management revenue reporting discrepancy (₹937 Cr stated vs. ₹1,366 Cr delivered); lack of clarification
Medium46% gap raises credibility flags and suggests potential segment/consolidated confusion or outdated guidance. Must be clarified next investor interaction to rebuild trust in management's on-call disclosures.
Capital markets cyclicality (IPO/M&A pipeline dependent); CAS regulations impacting derivatives (-₹2 Cr/month Aug–Sep)
MediumQ2 beat on 38 IPOs vs. 4 in Q1. Management expects normalization to 4–5% base growth; macro slowdown could worsen. Regulatory headwinds (CAS) to persist; fixed-income yield compression risk if duration increases.
Lending book collateral composition fragility to FPI shocks; yields stable 2.5% but cash collateral at 38–40%
LowIf FPI outflows accelerate, demand for cash collateral could spike, forcing yield compression. Management says yields would hold 2.5–2.8% even with 50% cash collateral, but execution risk on price acceptance is moderate.
The debate
What to watch next
1 · Asset management SIF approval (Nov–Dec 2026)
RTA/trustee approvals imminent. If SIF launches on time with credible AUM traction (₹500–750 crore target), AM path to profitability gains credibility. Delay or weak pickup is a red flag.
2 · Q3 cost trajectory (Jan 2027 earnings)
Employee cost growth, ESOP charge run-rate, and BAU opex adherence to ₹520–550 Cr guidance. Can management sustain 100–200 bps cost-to-income improvement while growing 20%+? Q3 will signal mid-year execution risk.
3 · Dividend reinstatement decision (April 2027)
Deferred H1 dividend signals debt paydown focus; reinstatement in H2 or April 2027 would signal balance-sheet confidence and unlock capital return narrative. Omission would suggest macro caution persists.
4 · FY27 full-year PAT growth actuals vs. 20%+ implied by guidance
H1 delivered 19.5% (with one-time charges). H2 must accelerate to hit low 20s; if not, cost inflation or macro headwinds are worse than guided. Organic margin trajectory is the north star.
The number to track
Adjusted operating PAT (ex one-time charges) and cost-to-income ratio. Adjusted operating PAT ~₹319 crore is the organic run-rate; that needs to compound 20%+ YoY for guidance credibility. Cost-to-income ~50% and the management's ability to hold it or improve further despite 19% employee cost inflation is the margin quality test. If adjusted operating PAT growth dips below 18% or cost-to-income creeps back above 51%, the bull case weakens — execution risk on cost control becomes material.
Nuvama delivered a solid quarter: 20%+ top-line growth, reiterated 20–25% wealth flow guidance, and 200 bps cost improvement. The market has priced in the execution case fairly — a 10% ATH drawdown reflects medium-term uncertainty on cost control and asset management profitability, not a panic. This is not a step-change, but steady execution: a high-quality franchise managing margin pressure and funding a multi-year transition. Hold for FY27 catalysts (SIF launch, Q3 cost trajectory, H2 dividend reinstatement). The risk case dominates if H2 adjusted PAT growth slips below 18% or employee cost inflation accelerates further.
Nuvama Q2 FY27: consolidated PAT +19% YoY to ₹303 Cr, +26% adjusted for one-off charge
PAT +19.5% YoY · revenue +20.4% · margins flat
₹1,366.06 Cr
+20.4% YoY
₹303.48 Cr
+19.5% YoY
22.19%
-0.1pp YoY
₹16.54
Nuvama Wealth Management's consolidated Q2 FY27 (quarter ended September 30, 2026) revenue from operations came in at ₹1,366.06 Cr, up 20.4% YoY but flat sequentially (-0.6% QoQ) from ₹1,374.88 Cr in Q1 FY27. Consolidated PAT was ₹303.48 Cr, up 19.5% YoY (down 0.7% QoQ from ₹305.64 Cr), with basic EPS of ₹16.54 (not annualised). Net profit margin held broadly flat at 22.2% versus 22.3% a year ago. Standalone PAT was ₹19.71 Cr on revenue of ₹201.78 Cr — this is the holding company's investment/advisory income only; the operating businesses sit in subsidiaries, so consolidated is the relevant basis for the group's performance and the two numbers are not meant to track each other.
Q2 FY-2027 vs prior quarters
The reported PAT print understates underlying growth: the quarter absorbed a one-time ₹16 Cr charge tied to the pre-closure of a Venture Debt Fund in the Asset Management business. Excluding this, the company's own 'Operating PAT' metric rose 26% YoY to ₹319 Cr (from ₹254 Cr), with RoE around 29% per management. The charge shows up directly in segment results — Asset Management's segment loss before tax widened to ₹34.1 Cr in Q2 from ₹7.7 Cr in Q1, taking the H1 cumulative segment loss to ₹41.8 Cr. That already exceeds management's own full-year guided peak loss of ₹35-40 Cr for the Asset Management business at just the half-year mark — a miss on that specific guidance line even as the rest of the group tracks or beats its targets. Wealth Management segment PBT grew 22% YoY to ₹184 Cr and Asset Services & Capital Markets PBT grew 34% YoY to ₹259 Cr, together more than offsetting the Asset Management drag.
The stock went into the print at ₹1,834.1, up 0.5% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters.
FY27 wealth & private flows ₹20-24k Cr (target); asset management cumulative loss ₹35-40 Cr this year (peak), then path to breakeven; asset services FY27 growth 20-25%; cost-to-income 55% (consolidated, with leverage from wealth/private).
— This quarter: met
Flow and growth metrics ran ahead of guidance elsewhere: Asset Services revenue grew 53% YoY in Q2 (43% YoY in H1), well above management's 20-25% FY27 growth guidance for that business. Wealth (MPIS) net flows hit a record ₹3,289 Cr in the quarter and Private (ARR) net flows a record ₹4,986 Cr, taking H1 combined wealth-and-private flows to roughly ₹12,400 Cr against the company's FY27 target band of ₹20,000-24,000 Cr — tracking the target if H2's typically stronger run-rate holds. Cost-to-income on the company's own net-revenue basis was about 54% (₹507 Cr costs on ₹937 Cr net revenues), in line with the 55% consolidated guidance management gave on the Q1 FY27 call. The same day as results, the Board approved up to ₹700 Cr of fresh investment into two wholly-owned subsidiaries (₹400 Cr into Nuvama Wealth Finance, ₹300 Cr into Nuvama Wealth and Investment), funding further balance-sheet scale-up in the NBFC and wealth-investment arms; client assets overall rose 25% YoY to ₹5.5 trillion, with MPIS/ARR assets up 27% YoY to nearly ₹1.1 trillion.
W1
Asset Management segment loss (₹41.8 Cr in H1 FY27) against management's full-year guided peak loss of ₹35-40 Cr — whether H2 narrows it back within that band
W2
H2 FY27 wealth & private net flows run-rate — H1 combined flows of ~₹12,400 Cr need roughly another ₹8,000-12,000 Cr in H2 to land inside the ₹20,000-24,000 Cr FY27 target
W3
Whether the ₹16 Cr Venture Debt Fund closure charge was one-time or recurs — next quarter's Asset Management segment PBT will confirm
Consolidated PBT (410.31) includes ₹1.15 Cr share of profit from associate+JV over the pre-share PBT of 409.16; PAT of 303.48 is Group total before a ₹0.04 Cr NCI allocation (owners' PAT ₹303.52 Cr). Q2 absorbed a one-time ₹16 Cr Venture Debt Fund pre-closure charge in Asset Management, which the company's own 'Operating PAT' of ₹319 Cr excludes. EPS is not annualised; all comparatives are restated for the December 2025 five-for-one stock split (FV ₹10→₹2), so DB's year-ago EPS of ₹70.54 (pre-split) is not comparable to the PDF's restated ₹14.11.
Strong growth hedged by cost inflation and AM transition drag
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Reaffirmed 20-25% growth on focus assets; beat on cost control. Missed on PAT growth (19.5% vs claimed 26%). Asset management loss trajectory tracking guidance.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Solid 20%+ top-line growth across diversified engines (wealth, lending, capital markets) and cost discipline (200 bps improvement YoY), but margin compression from employee inflation (+19%), asset management losses, and macro headwinds warrant caution. Deferred dividend signals balance-sheet prioritization over shareholder returns in uncertain environment.
₹1366.1 Cr
Revenue · +20.4% YoY₹303.5 Cr
Reported PAT · +19.5% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue ₹937 Cr with 21% YoY growth
MISSConsolidated revenue ₹1366.1 Cr with 20.4% YoY growth; management's ₹937 Cr figure not reconciled
PAT growth 26% on operating side
OVERSTATEDDelivered PAT ₹303.5 Cr, 19.5% YoY growth
Client assets ₹5.5 lakh Cr with 25% growth
METSupported by detailed discussion of wealth flows ₹3,300 Cr Q2
Asset services revenue growth 50% YoY
METAligned with strong quarter, but normalized growth expected 4-5%
Earnings quality
What changed since the last call
Dividend declared → withheld
DowngradeH1 FY27 dividend deferred to focus on debt paydown; debt-to-equity gearing from 2.9x → target 2.5x. Signals capital redeployment priority.
Cost-to-income trajectory
Upgrade200 bps improvement YoY; tracking to beat 55% consolidated target. Efficiency gains offset headcount additions and ESOP charges.
Asset services momentum
Upgrade50% YoY growth vs prior 20-25% guidance; client assets ₹1.63L Cr. But management guides normalized 4-5% going forward post-macro normalization.
Employee cost and ESOP impact
Downgrade19% YoY cost inflation; ₹6 Cr ESOP charge this quarter, ₹20 Cr quarterly ESOP run rate FY27. ₹25 Cr HO move charge FY27.
The Q&A
Analysts pressed hard on cost inflation trajectory (Q1-Q2 comp), competitive risks in clearing (domestic licenses proliferating), and asset management profitability timing. Management held firm on 20-25% growth, deflected on specific commodity trading and private credit fund launch timing, acknowledged macro headwinds but emphasized diversification moat.
Cost management and RM additions — Prayesh Jain, Motilal Oswal
AnsweredBoth wealth and private seeing 100-200 bps improvement this year. Asset management separate story; cost rise 100-200 bps annually from headcount/investments, but improving from efficiencies. Expected to taper over time.
Asset management profitability — Lalit Deo, Equirus Securities
AnsweredNot committed returns; fund was pre-winddown with unamortized distribution cost. Clearing yields between 2.5-2.8% next two years even if collateral composition changes due to G-sec collateral preference.
Domestic clearing business competition & market share — Sanketh Godha, Avendus Spark
PartialCompetitive field (18-19 players); we are ahead on value proposition and technology. Will need to maintain game; market is 6-7% PMS, 8-9% AIF share; can capture 25% of new inflows. Expect normal competitive dynamics.
Private wealth monetization and insurance share — Dipanjan Ghosh, Goldman Sachs
AnsweredInsurance in Wealth 12-13% of revenue, zero in Private. In Private, fixed income/ex-lending transactional income; 35-38% from monetization last 15 months; balance 60% non-monetization.
Capital markets ECM pipeline and mandates — Dipanjan Ghosh, Goldman Sachs
Answered15-18% of total transaction mandates; we range 18-20 mandates. Not strong in blocks; better in OIPs. 30 ECM and ~9 advisory mandates with ₹85-90 Cr revenue range currently.
Asset services client additions and price sensitivity — Sanidya, Unicorn Assets
AnsweredQ1 new client collateral normalized Q2. Assets up but revenue down due to normalization. 4-5% normal growth expected post-macro normalization. Options market back to normal; BSE/NSE also catching up.
Lending book growth and debt-to-equity gearing constraints — Prayesh Jain, Motilal Oswal
AnsweredAt 2.5x we can add ₹3,000-4,000 Cr book expansion. Internal accruals sufficient; may not need equity raise. ROE 29%, good opportunity to deploy capital via lending and asset management.
PAG stake sale and timeline — Prayesh Jain, Motilal Oswal
DodgedProcess being done by shareholders; if anything meaningful happens requiring disclosure, will immediately disclose.
Guidance
FY27 wealth & private focus assets growth 20-25%
HighReaffirmed on call; H1 delivering ~11-12% of opening balance (Q1+Q2 flows ₹8,300 Cr); tracking well within range.
Asset services normalized growth 4-5%
High50% growth Q2 acknowledged as exceptional; management expects normalization after macro stabilization and CAS impact dissipation.
Asset management on path to breakeven
MediumStill unprofitable; SIF launch expected to accelerate path but no specific breakeven timeline provided.
Cost-to-income 55% consolidated (prior); now tracking <55%
HighImproved 200 bps YoY. Management targets 100-200 bps further improvement. Employee cost +19% offset by productivity gains and operational leverage.
Operating PAT margin stable despite cost inflation
Medium26% operating PAT growth indicates pricing power and scale; net margin pressured by one-time charges.
HO move & new office infrastructure spending ₹25 Cr FY27
HighBKC headquarters finalized; rent-free period started November per accounting standard ROI treatment.
Risks the call surfaced
Cost inflation & margin compression
MediumEmployee cost +19% (₹382 Cr), ESOP ₹6 Cr this quarter recurring, 250 RM hires planned. BAU opex ₹520-550 Cr target implies 9% Y-o-Y growth. Offsets productivity gains.
Asset management unprofitability
MediumAsset management still loss-making; path to breakeven not quantified. SIF launch delayed. Cumulative losses tracking guidance ₹35-40 Cr peak but timeline to profitability unclear. May require longer subsidy or strategic pivot.
Domestic clearing competition
Medium18-19 domestic clearing competitors; new licenses being granted. Nuvama clearing is 49% JV (Motilal-Nuvama). Market share capture constrained by competitive intensity. Mandate-based business (ECM, advisory) also under pressure.
Capital markets cyclicality
MediumQ1 only 4 IPOs; Q2 jumped to 38. ECM mandate wins inconsistent. Fixed income exceptional Q1 (₹20 Cr extra) normalized Q2. CAS regulations impacting derivative volumes -₹2 Cr/month Aug-Sep. Equity derivatives (blocks, OIPs) also seasonal.
Lending book yield compression & collateral composition risk
LowLending book ₹6,000 Cr at 60% growth but yields stable 2.5%. Collateral composition: 38-40% cash, rest G-sec/securities. If FPI volatility increases collateral demand for cash, NIM could compress despite stable yield.
Management
Score 7/10. Ashish Kehair detailed and candid on business drivers (flow dynamics, tech adoption, competitive positioning). Acknowledged challenges (cost inflation, AM losses, macro uncertainty). Bharat Kalsi precise with numbers. Some deflection on specific timelines (private credit launch, commodity trading). Avoided question on PAG stake sale. Cost-to-income improved 200 bps vs guidance; wealth flows tracking 20-25% range (H1 ~11-12% of opening). Asset services beat 20-25% but acknowledged as exceptional. Asset management still unprofitable (vs breakeven target). One-time venture fund charge ₹16 Cr recognized transparently.
1 · Q3-Q4 FY27
Asset management SIF launch and path to profitability clarity
2 · April 2027
Private credit fund launch; target ₹1,500-2,000 Cr
3 · Nov-Dec 2026
Private equity fund launch (target ₹5,000 Cr); SIF RTA/trustee approvals
Deferred dividend signals balance-sheet prioritization over shareholder returns in uncertain environment.